Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Publication Information:
      Wiley, 2024.
    • Publication Date:
      2024
    • Abstract:
      Several ongoing trials are evaluating incretin-based therapies, including GLP-1 receptor agonists, for their effects on CKD and MASLD. These studies will offer insights into their potential for metabolic diseases in people with type 2 diabetes and obesity.
    • ISSN:
      2040-1124
      2040-1116
    • Accession Number:
      10.1111/jdi.14336
    • Rights:
      CC BY NC
    • Accession Number:
      edsair.doi.dedup.....2040780b52a91bb7d1804a00b2874e9f